Technology closer to young patientsG2B

Technology closer to young patients

,
On the occasion of the Rare Diseases Day, our CEO, Meritxell Teixidó, was interviewed by Mari Cruz Hernández…
talento científicotalento cientifico

Founding a company in times of pandemic

Our CEO, Meritxell Teixidó was invited to the “Talento Científico” podcast to talk about the Gate2Brain…

Sometimes the impossible only comes later

,
"Sometimes the impossible only comes later" Established in 2020, Gate2Brain is a spinoff that is based…
From researcher to entrepreneur/CEO : mission possible!

From researcher to entrepreneur/CEO Mission possible!

The last CHARM-EU podcast episode explores how do researchers can become entrepreneurs and the different…
Within the framework of the discussion-based interview series, Exploration Science, in which scientists talk about their ventures and areas of expertise, our CEO, Dr. Meritxell Teixidó, and the first and only APS American Peptide Idol joined @CEM's Dr. Wendy Hartsock to discuss the work @Gate2Brain is doing in pediatric oncology, dive into the technology, and talk about empathetic leadership and the power of diversity.CEM

Exploration Science with Dr. Wendy Harsock

Within the framework of the discussion-based interview series, Exploration Science, in which scientists…
Líderes que van más allá de las barrerasTedxSitges

TedxSitges 2021 Leaders beyond barriers

,
On November 6, Meritxell Teixidó, CEO and Co-Founder of Gate2Brain participated in the first edition…
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social